Shire PLC ADS (SHPG) News Nov 20, 2014, 5:17 p.m.
Post# of 250601
Posted On: 11/21/2014 1:13:13 AM
Shire PLC ADS (SHPG) News Nov 20, 2014, 5:17 p.m.
MarketWatch News on SHPG
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
AbbVie raises outlook as profit, sales beat 8:26 a.m. Oct. 31, 2014 - MarketWatch.com
Mylan 3Q profit soars as revenue tops estimates 5:19 p.m. Oct. 30, 2014 - MarketWatch.com
Scuttled ‘inversion’ deals pile up in wake of Treasury rules 3:14 p.m. Oct. 27, 2014 - Robert Schroeder
Shire lifts outlook after strong sales growth 7:33 a.m. Oct. 24, 2014 - MarketWatch.com
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
FTSE 100 climbs as oil stocks advance 12:03 p.m. Oct. 21, 2014 - Sara Sjolin
ASOS, Actelion, Akzo Nobel gain: Europe’s big stock movers 11:53 a.m. Oct. 21, 2014 - Sara Sjolin
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
AbbVie formally scuttles deal to buy Shire 7:02 p.m. Oct. 20, 2014 - Russ Britt
AbbVie, Shire terminate proposed merger, inversion 5:40 p.m. Oct. 20, 2014 - Russ Britt
AbbVie will pay Shire $1.635 billion break fee 5:29 p.m. Oct. 20, 2014 - Russ Britt
AbbVie, Shire deal cancellation rules out inversion 5:28 p.m. Oct. 20, 2014 - Russ Britt
AbbVie, Shire terminate proposed merger 5:25 p.m. Oct. 20, 2014 - Russ Britt
Paulson & Co. pushes for Allergan merger with Shire: report 1:52 p.m. Oct. 20, 2014 - Sital S. Patel
Hedge funds just can’t catch a break this month 3:13 p.m. Oct. 16, 2014 - Ben Eisen
AbbVie board recommends shareholders vote against Shire deal 9:01 a.m. Oct. 16, 2014 - Shayndi Raice
U.S. stocks cut losses in harrowing, volatile session 4:49 p.m. Oct. 15, 2014 - Barbara Kollmeyer
Southwestern tops gainers; financial stocks among biggest losers 3:51 p.m. Oct. 15, 2014 - Sue Chang
The potential for 10 years of negative returns as fear takes hold 8:47 a.m. Oct. 15, 2014 - Shawn Langlois
Other News on SHPG
Shire to Relocate Employees Under One Shire Program - Analyst Blog 4:35 p.m. Nov. 20, 2014 - Zacks.com
What Does The U.S. Dollar Bull Market Mean For European Equities? 12:38 p.m. Nov. 20, 2014 - Seeking Alpha
3 Stocks Dragging The Drugs Industry Downward 12:16 p.m. Nov. 19, 2014 - TheStreet.com
Shire to Relocate Jobs to Massachusetts 10:36 a.m. Nov. 19, 2014 - The Wall Street Journal Interactive Edition
What The U.S. Dollar Bull Market Mean For The Global Equity Markets? 10:25 a.m. Nov. 19, 2014 - Seeking Alpha
Shire To Relocate Over 500 Jobs To Massachusetts 8:30 a.m. Nov. 19, 2014 - benzinga.com
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook 1:00 a.m. Nov. 19, 2014 - Zacks.com
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews 1:00 a.m. Nov. 19, 2014 - Zacks.com
David Tepper Buys 4 New Stocks in Q3 9:55 p.m. Nov. 18, 2014 - GuruFocus.com
AstraZeneca Bets Long Term on Cancer Drugs 10:53 a.m. Nov. 18, 2014 - The Wall Street Journal Interactive Edition
Deal Boom Feeds on Surging Stocks 7:33 p.m. Nov. 17, 2014 - The Wall Street Journal Interactive Edition
Cramer: Pfizer Deal With Merck Leaves AstraZeneca In the Cold 11:47 a.m. Nov. 17, 2014 - TheStreet.com
Amicus Therapeutics' Fabry disease drug candidate improves cardiac health marker 7:31 a.m. Nov. 17, 2014 - Seeking Alpha
Actavis Nears Deal to Acquire Allergan 7:23 p.m. Nov. 16, 2014 - The Wall Street Journal Interactive Edition
Amicus Drug Improves Marker of Heart Health in Fabry Patients 10:01 a.m. Nov. 15, 2014 - TheStreet.com
Expect More Specialty Pharma Deals 7:40 a.m. Nov. 14, 2014 - Barrons.com
EU Probing Apple Inc. (AAPL), Starbucks (SBUX) Tax Deals 6:06 a.m. Nov. 14, 2014 - InvestorPlace.com
Hedge Fund Tales - Or What Is Wrong With Merger Arbitrage 12:57 p.m. Nov. 13, 2014 - TheStreet.com
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape 9:25 a.m. Nov. 13, 2014 - Zacks.com
Obama to Nominate Lazard Banker for a Top Treasury Post 6:10 p.m. Nov. 12, 2014 - The Wall Street Journal Interactive Edition
Press Releases on SHPG
Shire to Relocate Over 500 Jobs to Massachusetts 9:25 a.m. Nov. 19, 2014 - PR Newswire - PRF
Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms 7:00 a.m. Nov. 19, 2014 - PR Newswire - PRF
Collaboration, Breakthrough Therapy Designation, Clinical Trial Data, Voting Rights, and Financial Results - Research Reports on Johnson & Johnson, Merck, Amgen, Shire and HCA 8:50 a.m. Nov. 7, 2014 - PR Newswire - PRF
Shire to Participate at the Credit Suisse 2014 Global Healthcare Conference 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Critical Alerts For Apple, LightInTheBox, Time, 21st Century Fox and Shire Released By InvestorsObserver 9:31 a.m. Nov. 5, 2014 - PR Newswire - PRF
Cell Source CEO, Itamar Shimrat on his firm's transition from preclinical to human clinical trials 9:02 a.m. Nov. 5, 2014 - ACCESSWIRE
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
If You Purchased Shire plc American Depository Receipts ("ADRs"
During The Period Of June 20, 2014 And October 14, 2014 And Lost Money, Gardy & Notis, LLP Encourages You To Contact The Law Firm 8:38 a.m. Oct. 29, 2014 - PR Newswire - PRF
New Solution for Patients, Quarterly Financial Results, Clinical Study Initiation, Merger Updates, and Product Launch - Research Reports on CVS, Valeant, Regeneron, Allergan and Agilent 9:20 a.m. Oct. 23, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Shire plc: AbbVie Terminates Offer for Shire 5:22 p.m. Oct. 20, 2014 - PR Newswire - PRF
Announcement Of Termination Of Proposed AbbVie And Shire Transaction 5:12 p.m. Oct. 20, 2014 - PR Newswire - PRF
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Oct. 20, 2014 - PR Newswire - PRF
Interim Chief Financial Officer James Bowling to Step Down 2:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Shire plc: Statement re: AbbVie's Withdrawal of Recommendation 4:31 a.m. Oct. 16, 2014 - PR Newswire - PRF
AbbVie Board Recommends Stockholders Vote Against Shire Transaction 11:53 p.m. Oct. 15, 2014 - PR Newswire - PRF
Shire plc: Statement re: Waiver of Notice of AbbVie's Board Meeting 2:32 p.m. Oct. 15, 2014 - PR Newswire - PRF
Shire plc: Statement re: AbbVie's Intention to Reconsider Recommendation 2:13 a.m. Oct. 15, 2014 - PR Newswire - PRF
Announcement Of Notice To Shire Of AbbVie Board Intention To Reconsider Recommendation 7:44 p.m. Oct. 14, 2014 - PR Newswire - PRF
MarketWatch News on SHPG
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
AbbVie raises outlook as profit, sales beat 8:26 a.m. Oct. 31, 2014 - MarketWatch.com
Mylan 3Q profit soars as revenue tops estimates 5:19 p.m. Oct. 30, 2014 - MarketWatch.com
Scuttled ‘inversion’ deals pile up in wake of Treasury rules 3:14 p.m. Oct. 27, 2014 - Robert Schroeder
Shire lifts outlook after strong sales growth 7:33 a.m. Oct. 24, 2014 - MarketWatch.com
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
FTSE 100 climbs as oil stocks advance 12:03 p.m. Oct. 21, 2014 - Sara Sjolin
ASOS, Actelion, Akzo Nobel gain: Europe’s big stock movers 11:53 a.m. Oct. 21, 2014 - Sara Sjolin
3 stocks Ken Fisher likes 11:09 a.m. Oct. 21, 2014 - Insider Monkey
AbbVie formally scuttles deal to buy Shire 7:02 p.m. Oct. 20, 2014 - Russ Britt
AbbVie, Shire terminate proposed merger, inversion 5:40 p.m. Oct. 20, 2014 - Russ Britt
AbbVie will pay Shire $1.635 billion break fee 5:29 p.m. Oct. 20, 2014 - Russ Britt
AbbVie, Shire deal cancellation rules out inversion 5:28 p.m. Oct. 20, 2014 - Russ Britt
AbbVie, Shire terminate proposed merger 5:25 p.m. Oct. 20, 2014 - Russ Britt
Paulson & Co. pushes for Allergan merger with Shire: report 1:52 p.m. Oct. 20, 2014 - Sital S. Patel
Hedge funds just can’t catch a break this month 3:13 p.m. Oct. 16, 2014 - Ben Eisen
AbbVie board recommends shareholders vote against Shire deal 9:01 a.m. Oct. 16, 2014 - Shayndi Raice
U.S. stocks cut losses in harrowing, volatile session 4:49 p.m. Oct. 15, 2014 - Barbara Kollmeyer
Southwestern tops gainers; financial stocks among biggest losers 3:51 p.m. Oct. 15, 2014 - Sue Chang
The potential for 10 years of negative returns as fear takes hold 8:47 a.m. Oct. 15, 2014 - Shawn Langlois
Other News on SHPG
Shire to Relocate Employees Under One Shire Program - Analyst Blog 4:35 p.m. Nov. 20, 2014 - Zacks.com
What Does The U.S. Dollar Bull Market Mean For European Equities? 12:38 p.m. Nov. 20, 2014 - Seeking Alpha
3 Stocks Dragging The Drugs Industry Downward 12:16 p.m. Nov. 19, 2014 - TheStreet.com
Shire to Relocate Jobs to Massachusetts 10:36 a.m. Nov. 19, 2014 - The Wall Street Journal Interactive Edition
What The U.S. Dollar Bull Market Mean For The Global Equity Markets? 10:25 a.m. Nov. 19, 2014 - Seeking Alpha
Shire To Relocate Over 500 Jobs To Massachusetts 8:30 a.m. Nov. 19, 2014 - benzinga.com
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook 1:00 a.m. Nov. 19, 2014 - Zacks.com
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews 1:00 a.m. Nov. 19, 2014 - Zacks.com
David Tepper Buys 4 New Stocks in Q3 9:55 p.m. Nov. 18, 2014 - GuruFocus.com
AstraZeneca Bets Long Term on Cancer Drugs 10:53 a.m. Nov. 18, 2014 - The Wall Street Journal Interactive Edition
Deal Boom Feeds on Surging Stocks 7:33 p.m. Nov. 17, 2014 - The Wall Street Journal Interactive Edition
Cramer: Pfizer Deal With Merck Leaves AstraZeneca In the Cold 11:47 a.m. Nov. 17, 2014 - TheStreet.com
Amicus Therapeutics' Fabry disease drug candidate improves cardiac health marker 7:31 a.m. Nov. 17, 2014 - Seeking Alpha
Actavis Nears Deal to Acquire Allergan 7:23 p.m. Nov. 16, 2014 - The Wall Street Journal Interactive Edition
Amicus Drug Improves Marker of Heart Health in Fabry Patients 10:01 a.m. Nov. 15, 2014 - TheStreet.com
Expect More Specialty Pharma Deals 7:40 a.m. Nov. 14, 2014 - Barrons.com
EU Probing Apple Inc. (AAPL), Starbucks (SBUX) Tax Deals 6:06 a.m. Nov. 14, 2014 - InvestorPlace.com
Hedge Fund Tales - Or What Is Wrong With Merger Arbitrage 12:57 p.m. Nov. 13, 2014 - TheStreet.com
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape 9:25 a.m. Nov. 13, 2014 - Zacks.com
Obama to Nominate Lazard Banker for a Top Treasury Post 6:10 p.m. Nov. 12, 2014 - The Wall Street Journal Interactive Edition
Press Releases on SHPG
Shire to Relocate Over 500 Jobs to Massachusetts 9:25 a.m. Nov. 19, 2014 - PR Newswire - PRF
Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms 7:00 a.m. Nov. 19, 2014 - PR Newswire - PRF
Collaboration, Breakthrough Therapy Designation, Clinical Trial Data, Voting Rights, and Financial Results - Research Reports on Johnson & Johnson, Merck, Amgen, Shire and HCA 8:50 a.m. Nov. 7, 2014 - PR Newswire - PRF
Shire to Participate at the Credit Suisse 2014 Global Healthcare Conference 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Critical Alerts For Apple, LightInTheBox, Time, 21st Century Fox and Shire Released By InvestorsObserver 9:31 a.m. Nov. 5, 2014 - PR Newswire - PRF
Cell Source CEO, Itamar Shimrat on his firm's transition from preclinical to human clinical trials 9:02 a.m. Nov. 5, 2014 - ACCESSWIRE
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
If You Purchased Shire plc American Depository Receipts ("ADRs"
During The Period Of June 20, 2014 And October 14, 2014 And Lost Money, Gardy & Notis, LLP Encourages You To Contact The Law Firm 8:38 a.m. Oct. 29, 2014 - PR Newswire - PRF New Solution for Patients, Quarterly Financial Results, Clinical Study Initiation, Merger Updates, and Product Launch - Research Reports on CVS, Valeant, Regeneron, Allergan and Agilent 9:20 a.m. Oct. 23, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Shire plc: AbbVie Terminates Offer for Shire 5:22 p.m. Oct. 20, 2014 - PR Newswire - PRF
Announcement Of Termination Of Proposed AbbVie And Shire Transaction 5:12 p.m. Oct. 20, 2014 - PR Newswire - PRF
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Oct. 20, 2014 - PR Newswire - PRF
Interim Chief Financial Officer James Bowling to Step Down 2:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Shire plc: Statement re: AbbVie's Withdrawal of Recommendation 4:31 a.m. Oct. 16, 2014 - PR Newswire - PRF
AbbVie Board Recommends Stockholders Vote Against Shire Transaction 11:53 p.m. Oct. 15, 2014 - PR Newswire - PRF
Shire plc: Statement re: Waiver of Notice of AbbVie's Board Meeting 2:32 p.m. Oct. 15, 2014 - PR Newswire - PRF
Shire plc: Statement re: AbbVie's Intention to Reconsider Recommendation 2:13 a.m. Oct. 15, 2014 - PR Newswire - PRF
Announcement Of Notice To Shire Of AbbVie Board Intention To Reconsider Recommendation 7:44 p.m. Oct. 14, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼